Kevin Slawin
Chairman and CEO of PrintBio
Miami Beach, Florida
Overview
Work Experience
Chairman, Founder and CEO
2024 - Current
“Improving Healthspan and Increasing Lifespan” Senotherapeutix is a longevity holding company using advanced technologies to develop novel therapeutics targeting the fundamental mechanisms of aging. Its wholly owned subsidiary companies are developing products, both senolytic and senomorphic in nature, using our proprietary, state-of-the-art biotechnology platforms to restore the youthful balance of aged or “senescent” and young cells throughout the organs of the body. By targeting senescent cells, we have a unique opportunity to intervene in the aging process in ways that were once thought impossible.
Chairman, Founder and CEO
2024
"Improving Healthspan and Increasing Lifespan" Eos SENOLYTIX is a longevity company using advanced technologies to develop novel therapeutics targeting the fundamental mechanisms of aging. Its lead programs, PTC-2105 and PTC-2107, our proprietary senolytic peptides, restore the youthful balance of aged or “senescent” and young cells throughout the organs of the body. By targeting senescent cells for elimination, we have a unique opportunity to intervene in the aging process in ways that were once thought impossible.
Chairman, Founder and CEO
2024
"Improving Healthspan and Increasing Lifespan" Phoenix SENOLYTIX is a longevity company using advanced technologies to develop novel gene therapies targeting the fundamental mechanisms of aging. Its lead program, utilizing its proprietary purposeful cell elimination technology, ApoptiCIDe™, targets senescent cells for elimination, restoring the youthful balance of aged or “senescent” and young cells throughout the organs of the body. Our leadership team were the founders of Bellicum Pharmaceuticals, the first CAR-T cell company, in 2004. Inventors of CaspaCIDe™ at Bellicum, the most effective cell therapy safety switch validated in humans, they have now repurposed this technology, previously established as both safe and effective senolytic therapy in the p16Ink4a-ATTAC mouse model of genomic ablation of senescent cells, now as ApoptiCIDe™ to target senescent cells for non-inflammatory, apoptotic elimination, among other uses, in patients. By targeting senescent cells for elimination, we have a unique opportunity to intervene in the aging process in ways that were once thought impossible
Chairman, Founder and CEO
2023
“Powered by Advanced and Clinically Tested Bioprinting Technologies” PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients PrintBio is the only clinical- and commercial-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants. Leveraging first-in-human clinical experience, PrintBio is developing an array of products, beginning with 3DMatrix™, an FDA 510(k)-cleared 3D-printed monofilament bioresorbable surgical mesh, and next generation product 3DMatrix Dynaflex™ (FDA 510(k) clearance pending) that incorporates PrintBio’s proprietary Uniflex™ unidirectional flexible mesh technology, both utilizing proprietary technologies clinically tested in patients.
Founder, CEO and Chairman
2021
Applying high throughput DNA encoded library (DEL) drug screening technologies in novel ways to deliver therapeutics that address the most difficult problems in clinical medicine
DELIVER Therapeutics provides modern research tools and approaches are rapidly implicating new types of disease.
Founder and Managing Partner
2018
Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities
Rapha Capital Management is an investment company that invests in early stage biotechnology companies.
Chairman of the Board
2022
Conquering the Last Frontier in Patient Monitoring. FIZE® Medical offers the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter, providing unprecedented safety to both patients and their caregivers.
Board Member
2020 - 2022
Founder and Chairman
2021
Physicians, founders, executives and investors working to expand the entrepreneurial healthcare ecosystem in Miami
Miami Medicos is a member organization supporting the business needs of Biopharma, medical devices and services companies.
Chairman of the Board
2021
Building a Best-in-class Urologic Oncology Company. Developing technologies to better visualize and treat urologic cancers through minimally invasive procedures in the physicians’ office
Imagin Medical is a surgical imaging company.
Raised $11,000,000.00 from Rapha Capital Management and Rapha Capital Management.
Founding Board Member
2021
Enabling promising early-stage life science companies to develop the next generation of innovative therapies to improve the lives of patients. We want to do this by offering them Contract Research Organization (CRO) Services, newly renovated wet-lab space, process and analytical development support, short-term financing, and third-party due diligence validation, among other services.
K2bio is a contract research organization that assists early-stage life science companies in advancing innovative therapies.
Raised $615,522.00.